by [email protected] | Nov 26, 2024 | ENZC
Enzolytics, Inc. (ENZC), a biotechnology company focused on developing therapies for infectious diseases, presents substantial risks for investors. These risks arise from financial instability, legal scrutiny, share dilution, and operational inefficiencies. Financial...